Quantcast

Latest Grifols S.A. Stories

2014-04-17 08:28:45

- Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries BARCELONA, Spain, April 17, 2014 /PRNewswire/

2014-04-04 12:27:38

BARCELONA, Spain, April 4, 2014 /PRNewswire/ -- Grifols, S.A.

2013-09-26 23:02:12

Reportbuyer.com just published a new market research report:

2011-06-03 12:56:00

BARCELONA, Spain, June 3, 2011 /PRNewswire/ -- Grifols, S.A. (NASDAQ: GRFS) ("Grifols") a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that on June 1, 2011, Grifols completed its acquisition of Talecris Biotherapeutics Holdings Corp.

2011-06-01 05:30:00

RESEARCH TRIANGLE PARK, N.C., June 1, 2011 /PRNewswire/ -- Grifols, S.A. (GRF.MC) and Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) announced today that the U.S.


Word of the Day
pawl
  • A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.
The word 'pawl' probably comes from a Latin word meaning 'stake'.
Related